Kairos Pharma, Ltd. , a clinical stage biopharmaceutical company, today provides a letter to stockholders from CEO John Yu, M.D.: To our valued stockholders, As we reflect on the Company's progress ...

Important Information Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular ...